BioNexus Gene Lab Corp
BGLC- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001737523
No open-market purchases or sales by BioNexus Gene Lab Corp insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $27.2K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding BioNexus Gene Lab Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 5 | +5 |
| Shares | 0 | 203.6K | +203.6K |
| Value | $0 | $171.4K | +$171.4K |
New holders (5)
Institutions that held BioNexus Gene Lab Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 59,688 | $50.0K | 0.00% |
| Citadel Advisors LLC | 51,751 | $43.5K | 0.00% |
| HRT Financial LP | 45,467 | $38.0K | 0.00% |
| Two Sigma Securities, LLC | 22,994 | $20.0K | 0.00% |
| Geode Capital Management, LLC | 23,681 | $19.9K | 0.00% |
Sold out (0)
Institutions that held BioNexus Gene Lab Corp at the end of Q2 2023 and filed for Q3 2023 without it.
None.